Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver.
Ontology highlight
ABSTRACT: Transgenic mice overexpressing growth hormone (GH) spontaneously develop liver tumors, including hepatocellular carcinoma (HCC), within a year. The preneoplastic liver pathology in these mice recapitulates that observed in humans at high risk of developing hepatic cancer. Although increased expression of galectin 1 (GAL1) in liver tissue is associated with HCC aggressiveness, a link between this glycan-binding protein and hormone-related tumor development has not yet been explored. In this study, we investigated GAL1 expression during liver tumor progression in mice continuously exposed to high levels of GH. GAL1 expression was determined by Western blotting, RT-qPCR and immunohistochemistry in the liver of transgenic mice overexpressing GH. Animals of representative ages at different stag
SUBMITTER: Bacigalupo ML
PROVIDER: S-EPMC6652241 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA